Addex Therapeutics Ltd (ADXN)
8.95
+0.10
(+1.13%)
USD |
NASDAQ |
May 03, 16:00
8.60
-0.35
(-3.91%)
After-Hours: 20:00
Addex Therapeutics Free Cash Flow: -8.908M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -8.908M |
| September 30, 2023 | -11.75M |
| June 30, 2023 | -11.87M |
| March 31, 2023 | -14.54M |
| December 31, 2022 | -17.24M |
| September 30, 2022 | -17.15M |
| June 30, 2022 | -17.05M |
| March 31, 2022 | -18.30M |
| December 31, 2021 | -16.12M |
| Date | Value |
|---|---|
| September 30, 2021 | -11.85M |
| June 30, 2021 | -12.46M |
| March 31, 2021 | -11.81M |
| December 31, 2020 | -13.06M |
| September 30, 2020 | -13.92M |
| June 30, 2020 | -15.67M |
| March 31, 2020 | -11.31M |
| December 31, 2019 | -9.573M |
Free Cash Flow Range, Past 5 Years
-18.30M
Minimum
Mar 2022
-8.908M
Maximum
Dec 2023
-13.68M
Average
-13.06M
Median
Dec 2020
Free Cash Flow Benchmarks
| AC Immune SA | -68.17M |
| CRISPR Therapeutics AG | -272.34M |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | -66.61M |
| MoonLake Immunotherapeutics | -42.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.5563M |
| Cash from Investing (Quarterly) | -0.0012M |
| Cash from Financing (Quarterly) | -0.1643M |
| Free Cash Flow Per Share (Quarterly) | -0.775 |
| Free Cash Flow to Equity (Quarterly) | -0.5575M |
| Free Cash Flow to Firm (Quarterly) | -0.5575M |
| Free Cash Flow Yield | -160.8% |